Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Concordia Healthcare Corp. T.CXR.R

TSX:CXR.R - Post Discussion

View:
Post by StockPicker88 on Apr 09, 2016 2:44pm

Tech my view

Chart does not look pretty for CXR. The stock is trending lower. This has nothing to do with fundamentals. Hedge funds over bought this stock and now they are selling on any rally. The bigger problem is that whole healthcare is over bought and are under pressure. Allergan is a prime example. The company is ok fundamentally but too many funds own the stock. Now the Pfizer deal is off. A lot of these funds have to sell. This process could take some time.

The only bright spot I see is IBB. It looks like it had a double bottom formation and broke out last week. A little pull back in the past couple sessions but that is pretty common. If this breakout is for real, it could potentially carry CXR with it. Right now there is very little buying or selling interest in CXR at this price level. Index buying could easily move it. 

Next resistance is $39ish and then $47ish.
Comment by FullReversal on Apr 09, 2016 2:59pm
Great post. Anyone have an insider rebuttal for the lettuce apparent "mind manipulation" attempt here? The facts are that insiders do appear to have bought at the lows and sold at the last cycle. https://www.canadianinsider.com/company?menu_tickersearch=CXR So not a very trustworthy stock once it hits the $50-$60 range!? As an investor, I prefer a stock I can buy and hold.  If ...more  
Comment by puma1 on Apr 09, 2016 6:33pm
The IBB looks like a DB, but I don't think it will break yet. It is still too far below the 200 mda and it has to get over that first imo to signal. We are probably a choppy sideways for a while. CXR has to get closer to the end of Q2 and when it gets picked up they will be showing $1.60 plus the trend will flow.
Comment by StockPicker88 on Apr 09, 2016 7:33pm
Good point. Like I said, individual charts still look pretty bad and that may drag on index. On the other hand, US market corrects real fast these days. There seems to be a lot of captial sitting on the side line watiing for opportunities. We will see what happens in the next few days. 
Comment by puma1 on Apr 10, 2016 7:22am
with all the white noise in the segment it is just too easy to cast doubt on any of the sector and EPS guidance. U can start, run, and maintain a short campaign only while the stock is trading on guidance and not history. There was a CIBC analyst in Q4 who got this and early on had one of the lower shorter term targets and said range bound trapped. We have 6 more months before the forward guidance ...more  
Comment by FullReversal on Apr 10, 2016 11:14am
Right, what you are talking about here is there might still be some cause for the short campaign to continue.  The bullboard action certainly confirms this. But guys, we aren't talking about CXR at $100 now, we're talking about CXR is the low $30s with short sellers and their operatives all over this. You're a market-connect guy right Puma1?    You don't work for ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities